HUP0104760A2 - Eljárás és készítmény a bél épségének megtartására és helyreállítására - Google Patents
Eljárás és készítmény a bél épségének megtartására és helyreállításáraInfo
- Publication number
- HUP0104760A2 HUP0104760A2 HU0104760A HUP0104760A HUP0104760A2 HU P0104760 A2 HUP0104760 A2 HU P0104760A2 HU 0104760 A HU0104760 A HU 0104760A HU P0104760 A HUP0104760 A HU P0104760A HU P0104760 A2 HUP0104760 A2 HU P0104760A2
- Authority
- HU
- Hungary
- Prior art keywords
- fatty acid
- polyunsaturated fatty
- amount
- restitution
- maintenance
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000012423 maintenance Methods 0.000 title 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 4
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract 2
- 210000000936 intestine Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A tal lm ny t rgya elj r s a bél épségének megtart s ra és helyre llíts nak elősegítésére egy ilyen kezelésre szoruló egyénen. A tal lm nyszerinti elj r s abban ll, hogy ennek az egyénnek olyan készítménytadagolnak, amely legal bb egy <n-6< t"bbsz"r"sen telítetlen zsírsav éslegal bb egy <n-3< t"bbsz"r"sen telítetlen zsírsav kombin ciój nak hatsos mennyiségét tartalmazza, ahol az <n-6< zsírsavban a telítetlenk"tések a 6-os és az utolsó szénatom k"z"tt, míg az <n-3< zsírsavban a3-as és az utolsó szénatom k"z"tt vannak. A készítmény az n-6t"bbsz"r"sen telítetlen zsírsavat 4-50mg/100 ml mennyiségben, míg azn-3 t"bbsz"r"sen telítetlen zsírsavat 4-50 mg/ 100 ml mennyiségbentartalmazza. A készítmény az n-6 t"bbsz"r"sen telítetlen zsírsavat azn-3 t"bbsz"r"sen telítetlen zsírsavhoz viszonyítva (1:1)-(2,5:1) arnyban tartalmazza. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11237498P | 1998-12-15 | 1998-12-15 | |
PCT/US1999/029478 WO2000035443A1 (en) | 1998-12-15 | 1999-12-13 | Method and composition for the maintenance and restitution of gut integrity |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0104760A2 true HUP0104760A2 (hu) | 2002-04-29 |
Family
ID=22343574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0104760A HUP0104760A2 (hu) | 1998-12-15 | 1999-12-13 | Eljárás és készítmény a bél épségének megtartására és helyreállítására |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1140063A1 (hu) |
JP (1) | JP2002532420A (hu) |
KR (1) | KR20020002361A (hu) |
CN (1) | CN1330542A (hu) |
AR (1) | AR021669A1 (hu) |
AU (1) | AU3119600A (hu) |
BR (1) | BR9916156A (hu) |
CA (1) | CA2351469A1 (hu) |
EA (1) | EA200100662A1 (hu) |
HU (1) | HUP0104760A2 (hu) |
IL (1) | IL143322A0 (hu) |
NO (1) | NO20012947D0 (hu) |
PL (1) | PL348810A1 (hu) |
WO (1) | WO2000035443A1 (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1863463B (zh) | 2003-06-23 | 2011-05-04 | 雀巢技术公司 | 用于促进肠道屏障成熟的营养组合物 |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
JP2007063219A (ja) * | 2005-09-01 | 2007-03-15 | Juntendo | 新生児壊死性腸炎疾患予防剤 |
ES2674430T3 (es) | 2010-12-29 | 2018-06-29 | Abbott Laboratories | Producto nutricional para mejorar la tolerancia, digestión y absorción de nutrientes liposolubles en un lactante, niño pequeño o niño |
MX2017003660A (es) * | 2014-09-30 | 2017-06-26 | Nestec Sa | Composicion nutricional que se usa para promover la maduracion y/o reparacion del intestino y/o del higado. |
WO2023245470A1 (zh) * | 2022-06-22 | 2023-12-28 | 南方医科大学珠江医院 | Mdp类似物在制备用于治疗炎症性肠病的药物中的用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670285A (en) * | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
DE3603000A1 (de) * | 1986-01-31 | 1987-08-06 | Milupa Ag | Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen |
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
US5444054A (en) * | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
DE4417851C1 (de) * | 1994-05-20 | 1995-10-05 | Horst Heirler | Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung |
EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
US5993221A (en) * | 1997-05-01 | 1999-11-30 | Beth Israel Deaconess Medical Center, Inc. | Dietary formulation comprising arachidonic acid and methods of use |
-
1999
- 1999-12-13 JP JP2000587763A patent/JP2002532420A/ja active Pending
- 1999-12-13 KR KR1020017007472A patent/KR20020002361A/ko not_active Application Discontinuation
- 1999-12-13 IL IL14332299A patent/IL143322A0/xx unknown
- 1999-12-13 EA EA200100662A patent/EA200100662A1/ru unknown
- 1999-12-13 PL PL99348810A patent/PL348810A1/xx not_active Application Discontinuation
- 1999-12-13 BR BR9916156-7A patent/BR9916156A/pt not_active Application Discontinuation
- 1999-12-13 AU AU31196/00A patent/AU3119600A/en not_active Abandoned
- 1999-12-13 HU HU0104760A patent/HUP0104760A2/hu unknown
- 1999-12-13 EP EP99965234A patent/EP1140063A1/en not_active Withdrawn
- 1999-12-13 CA CA002351469A patent/CA2351469A1/en not_active Abandoned
- 1999-12-13 WO PCT/US1999/029478 patent/WO2000035443A1/en not_active Application Discontinuation
- 1999-12-13 CN CN99814534A patent/CN1330542A/zh active Pending
- 1999-12-14 AR ARP990106370A patent/AR021669A1/es unknown
-
2001
- 2001-06-14 NO NO20012947A patent/NO20012947D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000035443A9 (en) | 2000-12-07 |
IL143322A0 (en) | 2002-04-21 |
AU3119600A (en) | 2000-07-03 |
JP2002532420A (ja) | 2002-10-02 |
BR9916156A (pt) | 2001-09-04 |
CN1330542A (zh) | 2002-01-09 |
NO20012947L (no) | 2001-06-14 |
KR20020002361A (ko) | 2002-01-09 |
PL348810A1 (en) | 2002-06-17 |
NO20012947D0 (no) | 2001-06-14 |
EP1140063A1 (en) | 2001-10-10 |
AR021669A1 (es) | 2002-07-31 |
WO2000035443A1 (en) | 2000-06-22 |
CA2351469A1 (en) | 2000-06-22 |
EA200100662A1 (ru) | 2001-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Siegel et al. | The differential effects of prenatal and postnatal audiogenic stress on fluctuating dental asymmetry | |
WO2001070664A3 (en) | Lipoxin analogs and methods for the treatment of periodontal disease | |
HUP9900864A2 (hu) | Eljárás esszenciális aminosavak felgyülemlésének növelésére magokban | |
MA24425A1 (fr) | Preventio de la perte et restauration de la masse osseuse par certains agonistes des prostaglandines. | |
HUP0104760A2 (hu) | Eljárás és készítmény a bél épségének megtartására és helyreállítására | |
AR002442A1 (es) | Formulaciones orales de ibuprofeno s (+) | |
TR199902802T2 (xx) | Kardiyovask�ler hastal�klar ve enflamatuar hastal�klar�n tedavisi i�in probukol monoesterleri. | |
ATE215320T1 (de) | Nahrungszusammensetzungen in verschiedenen formen | |
GB2318977B (en) | Compositions | |
ATE197389T1 (de) | Zahnimplantat und verfahren zu seiner herstellung | |
PT859608E (pt) | Tratamento de niddm com agonistas de rxr | |
IS2983B (is) | Fastar lyfjasamsetningar sem innihalda 4-amínó-3-setnar-smjörsýruafleiður valdar úr gabapentíni og/eða pregabalíni og aðferð við að framleiða þær | |
Li et al. | The effects of fixed orthodontic appliances on saliva flow rate and saliva electrolyte concentrations | |
DE59000791D1 (de) | Einzelzahnimplantat. | |
CA2130575A1 (en) | Petroleum Wax-Free Chewing Gums Having Improved Flavor Release | |
PT1216041E (pt) | Dieta com elevado teor de lipidos | |
HUP0003899A2 (hu) | Kétkomponensű fogápoló készítmény a fog fluoridtartalmának növelésére | |
DK0560425T3 (da) | Forbedrede chokoladesammensætninger baseret på hardstock-fedtadditiver | |
BR9811888A (pt) | Composições aromatizantes melhoradas contendo n-etil-p-mentano-3-carboxamida e método para produzir e usar as mesmas | |
PL325472A1 (en) | Method of marking objects and objects and marked thereby | |
PT1051159E (pt) | Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose | |
ATE445332T1 (de) | Glutaminhaltige zusammensetzung gegen diarrhö | |
WO2002092779A3 (en) | Method for enriching tissues in long chain polyunsaturated fatty acids | |
BR9809673A (pt) | Derivados de triptolida úteis no tratamento de doenças autoimunes | |
EP0843109A3 (en) | Drum brake device |